Literature DB >> 16257508

Type 1 diabetes genes and pathways shared by humans and NOD mice.

Linda S Wicker1, Jan Clark, Heather I Fraser, Valerie E S Garner, Andrea Gonzalez-Munoz, Barry Healy, Sarah Howlett, Kara Hunter, Dan Rainbow, Raymond L Rosa, Luc J Smink, John A Todd, Laurence B Peterson.   

Abstract

The identification of causative genes for the autoimmune disease type 1 diabetes (T1D) in humans and candidate genes in the NOD mouse has made significant progress in recent years. In addition to sharing structural aspects of the MHC class II molecules that confer susceptibility or resistance to T1D, genes and pathways contributing to autoimmune pathogenesis are held in common by the two species. There are data demonstrating a similar need to establish central tolerance to insulin. Gene variants for the interacting molecules IL2 and CD25, members of a pathway that is essential for immune homeostasis, are present in mice and humans, respectively. Variation of two molecules that negatively regulate T cells, CTLA-4 and the tyrosine phosphatase LYP/PEP, are associated with susceptibility to human and NOD T1D. These observations underscore the value of the NOD mouse model for mechanistic studies on human T1D-associated molecular and cellular pathways.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16257508     DOI: 10.1016/j.jaut.2005.09.009

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  60 in total

Review 1.  Genetics, pathogenesis and clinical interventions in type 1 diabetes.

Authors:  Jeffrey A Bluestone; Kevan Herold; George Eisenbarth
Journal:  Nature       Date:  2010-04-29       Impact factor: 49.962

Review 2.  Use of nonobese diabetic mice to understand human type 1 diabetes.

Authors:  Terri C Thayer; S Brian Wilson; Clayton E Mathews
Journal:  Endocrinol Metab Clin North Am       Date:  2010-07-08       Impact factor: 4.741

Review 3.  Tolerance strategies employing antigen-coupled apoptotic cells and carboxylated PLG nanoparticles for the treatment of type 1 diabetes.

Authors:  Suchitra Prasad; Dan Xu; Stephen D Miller
Journal:  Rev Diabet Stud       Date:  2012-12-28

4.  Novel epitope begets a novel pathway in type 1 diabetes progression.

Authors:  Jeffrey A Frelinger
Journal:  J Clin Invest       Date:  2008-10       Impact factor: 14.808

Review 5.  Dendritic cells and the maintenance of self-tolerance.

Authors:  Penelope A Morel; Michael S Turner
Journal:  Immunol Res       Date:  2011-08       Impact factor: 2.829

Review 6.  After GWAS: mice to the rescue?

Authors:  Joerg Ermann; Laurie H Glimcher
Journal:  Curr Opin Immunol       Date:  2012-09-29       Impact factor: 7.486

7.  Monoclonal antibody blocking the recognition of an insulin peptide-MHC complex modulates type 1 diabetes.

Authors:  Li Zhang; Frances Crawford; Liping Yu; Aaron Michels; Maki Nakayama; Howard W Davidson; John W Kappler; George S Eisenbarth
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-03       Impact factor: 11.205

Review 8.  Checkpoints in lymphocyte development and autoimmune disease.

Authors:  Harald von Boehmer; Fritz Melchers
Journal:  Nat Immunol       Date:  2009-12-17       Impact factor: 25.606

9.  Genetic interactions among Idd3, Idd5.1, Idd5.2, and Idd5.3 protective loci in the nonobese diabetic mouse model of type 1 diabetes.

Authors:  Xiaotian Lin; Emma E Hamilton-Williams; Daniel B Rainbow; Kara M Hunter; Yang D Dai; Jocelyn Cheung; Laurence B Peterson; Linda S Wicker; Linda A Sherman
Journal:  J Immunol       Date:  2013-02-20       Impact factor: 5.422

10.  Aberrant endometrial features of pregnancy in diabetic NOD mice.

Authors:  Suzanne D Burke; Hongmei Dong; Aleah D Hazan; B Anne Croy
Journal:  Diabetes       Date:  2007-09-07       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.